Dr. White focuses on antitrust, intellectual property, and tax/transfer pricing matters in a range of industries, with a particular interest in health care issues. He has worked on general commercial business litigations such as allegations of false advertising and breach of contract; investigations into alleged off-label promotion of prescription drugs; and the economic impact of generic entry and substitution. He has also analyzed economic issues relevant to class certification and quantification of damages. Dr. White has managed numerous commercial litigation matters, supporting academic and industry experts with expertise in industrial organization, statistics, health economics, and marketing. His tax and transfer pricing work has evaluated the arm’s length nature of pricing in intercompany transactions, and the estimation of useful economic lives for various tangible and intangible assets. His non-litigation work has involved the development of empirical models for determining factors that may help identify patients at risk of prescription opioid abuse, as well as the estimation of societal economic costs of prescription opioid abuse. His research and publications have focused on specific health economics issues, such as the costs of abuse, as well as the theory and implementation of various price indexes. Dr. White is an adjunct faculty member in the Department of Economics at Northeastern University in Boston.